ABSTRACT Phytase hydrolyzes phytate rendering phosphorus available for intestinal absorption, while systemic neutralization of fibroblast growth factor 23 (FGF-23), using anti-FGF-23 antibody, has been shown to increase phosphate retention. Hence, neutralization of FGF-23 should be additive with phytase in reducing dietary non-phytate phosphorus (nPP) needs in chickens fed plant-based diets rich in phytic acid. This study was designed to test the additive effects of maternally derived anti-FGF-23 antibody and dietary phytase on the performance of chicks fed a low nPP diet from one to 14 d. Single Comb White Leghorn laying hens were vaccinated with either an adjuvant control or a synthetic FGF-23 peptide (GMNPPPYS). Chicks from vaccinated hens with control or anti-FGF-23 maternal antibodies were fed either a diet containing 0.2% nPP and 0.9% calcium with or without 500 unit phytase per kg of diet (2 × 2 factorial with main effects of antibody type and phytase addition, n = 15 pens of chicks/treatment). A significant interaction between dietary phytase and maternally derived anti-FGF-23 antibody on growth and feed efficiency was observed (P ≤ 0.05), in which chicks receiving either phytase or maternally derived anti-FGF-23 antibody had improved body weight gain (21 or 15%, respectively) and feed efficiency (16 or 18%, respectively) as compared to chicks with control antibody and not fed phytase. Both phytase and maternally derived anti-FGF-23 antibody independently increased (P ≤ 0.05) plasma phosphate (11 and 11%, respectively) and percent tibiotarsus ash (13 and 11%, respectively). Significant main effects and the lack of an interaction supported an additive effect of phytase and anti-FGF-23 antibody on plasma phosphate and percent tibiotarsus ash. Feeding phytase to chicks fed 0.2% nPP increased plasma FGF-23 levels by 22% (P ≤ 0.05); however, no effects of anti-FGF-23 antibody on plasma FGF-23 levels were observed. In conclusion, dietary phytase and presence of anti-FGF-23 antibody have an additive effect on plasma phosphate and tibiotarsus ash in chicks fed low nPP diets. Data support that phytase and anti-FGF-23 antibody increase phosphate utilization by different mechanisms.
INTRODUCTION
Osteocytes-derived fibroblast growth factor 23 (FGF-23) is a hormone essential for preventing increased plasma phosphate levels above normal physiological levels (White et al., 2000) .
As blood phosphate increases due to the dietary consumption of phosphate or the mobilization of bone to maintain blood calcium levels, FGF-23 restores blood phosphate to normal levels by reducing intestinal phosphate absorption and increasing renal phosphate excretion. FGF-23 indirectly down-regulates intestinal sodium-dependent phosphate (NaPi) co-transporter IIb (intestinal transporter for active phosphate phosphorus requirements of animals. Indeed, maternally derived anti-FGF-23 peptide antibody prevented a reduction in plasma phosphate level and tibiotarsus ash content in chicks fed a phosphorus-deficient diet, suggesting that the phosphorus requirements of chicks was reduced when FGF-23 was neutralized (Bobeck et al., 2012) .
Currently, phytase is widely used in the poultry industry to increase the digestibility of phytate rendering the phosphate available for absorption (Waldroup et al., 2000; Li et al., 2015) . Increased phytate phosphorus digestibility when dietary phytase is used reduces the dietary need for inorganic phosphate; however, phytase does not increase the bioavailability of dietary phosphate. We hypothesized that neutralization of FGF-23 (using an antibody) would increase phosphate bioavailability and would be additive with phytase because phytase improves phytate phosphate digestibility and FGF-23 neutralization improves phosphate transport and retention.
In this study, chicks with maternally derived anti-FGF-23 antibody were fed phosphorus deficient diets with or without the supplementation of phytase. Chick performance, plasma phosphate and hormones, tibiotarsus ash content, and phosphorus excretion were measured.
MATERIALS AND METHODS
All animal procedures described were approved by the College of Agricultural and Life Sciences Animal Care and Use Committee at the University of Wisconsin-Madison.
Birds and Diets
A FGF-23 peptide (GMNPPPYS, internally coded as NP1, synthesized by GeneScript, Piscatawy, NJ), which has been shown to reduce excreta phosphorus of laying hens and chicks (Ren et al., 2016a,b) , was used in this study to stimulate anti-FGF-23 neutralizing antibodies in Single Comb White Leghorn laying hens. Laying hens (vaccinated with either an adjuvant control, n = 14; or a synthetic FGF-23 peptide, n = 15) used in a previous study (Ren et al., 2016b ) received a booster injection (using the same procedures as described in Ren et al., 2016b) 6 mo following the primary injection to maintain antibody levels.
Seven d following the final booster injection, egg yolks from hens were collected and extracted by acidified phosphate-buffered saline (PBS) according to Trott et al. (2009) for determining the presence of anti-FGF-23 peptide antibody. Then, hens were artificially inseminated once a wk with pooled New Hampshire rooster semen for 2 weeks. Eggs were collected and incubated for 21 d and chicks with (from FGF-23 peptide vaccinated hens) or without (from control vaccinated hens) maternally derived anti-FGF-23 antibody were hatched and identified as to source. Chicks from each of the maternal groups were assigned to either a phosphorus-deficient diet (with 0.2% non-phytate phosphorus [nPP] and 0.9% calcium) or the same diet plus phytase (500 phytase unit [FTU] per kg of diet) for 14 d (Table 1) as a 2 × 2 factorial arrangement of treatment (with phytase and antibody representing the main effects, 15 pens of 5 to 6 chicks per treatment, 60 pens in total). The study length was 14 d to assure maternal antibodies were present to the end of the study (Brierley and Hemmings, 1956; Rose and Orlans, 1981) . Body weight (BW) and feed intake (FI) of chicks were recorded at 14 d of age, and gain to feed ratio (G:F) was calculated. On d 14, one chick per pen was randomly selected, bled (heparin as an anticoagulant, centrifuged for 20 min at 1,000 × g at 4 • C, stored at -80 • C), and the tibiotarsus samples (both, pooled) were collected (stored at -20
• C). The 24 h total excreta samples were collected on d 14 on pen basis.
Anti-FGF-23 Antibody Assay
The presence of anti-FGF-23 peptide specific antibody in egg yolk and chick plasma was determined using an indirect enzyme-linked immunosorbent assay (ELISA) similar to those described in Bobeck et al. (2015a) and Bobeck et al. (2015b) . Briefly, FGF-23 peptide was conjugated to ovalbumin (OVA, Sigma, St. Louis, MO) according to Arendt et al. (2016) , and then coated to 96-well plates (100 μg per plate). Egg yolk (acidified PBS extracted, pH = 5) and chick plasma samples were diluted to 1:1,000, 1:2,000, 1:4,000, and 1:8,000 for the ELISA assay of reactivity against FGF-23 peptide-OVA conjugate.
Plasma Parameters
Colorimetric assay kits (BioVision Inc., Milpitas, CA) were used to analyze phosphate and calcium concentrations of chick plasma. Chick plasma levels of FGF-23, 1,25(OH) 2 D 3 and intact parathyroid hormone (iPTH) were determined using ELISA kits MBA034670 (double-antibody-sandwich method), MBS737706 (competitive method), and MBS043033 (double-antibody-sandwich method), respectively, according to the manufacturer's manual (My Biosource, San Diego, CA). An EL800 plate reader (BioTek Winooski, VT) was used to read the 96-well plates in all these assays.
Tibiotarsus Ash Determination
Tibiotarsi samples were oven-dried at 108
• C for 24 h, and lipids were extracted in a Soxhlet apparatus for 16 h using refluxing ethyl ether. Extracted tibiotarsi were then oven-dried at 108
• C for 24 h, weighed, and ashed in a muffle furnace for 24 h at 600
• C (method 942.05; AOAC, 2006). Tibiotarsus ash content was calculated as the amount of ash in percent of the dry fat-free tibiotarsus.
Excreta Phosphorus Analysis
The 24 h total excreta samples from each pen were oven-dried, weighed, and sent to University of Wisconsin Soil Testing Laboratories for the determination of phosphorus concentration using a colorimetric method (Peters et al., 2003) . The total 24 h excreta weight and total 24 h phosphorus excretion were calculated per chick/100 g body weight.
Statistical Analysis
Data were analyzed by ANOVA as a 2 × 2 factorial arrangement with phytase and antibody as main effects using GLM procedures of SPSS 23 (IBM Corp., Chicago, IL). Posthoc analysis (Duncan's test) was applied to denote treatment differences when any of the interactions showed significance. Statements of the additivity vs. non-additivity of phytase and antibody were based on Snedecor and Cochran (1967) , in which when both main effects were significant and there was no interaction, the treatments were considered additive, whereas when there was an interaction between phytase and antibody, the treatments were considered nonadditive. Pen was the experimental unit, and the results were considered significantly different at P ≤ 0.05.
RESULTS

Presence of Anti-FGF-23 Antibody
The ability of egg yolk antibody to FGF-23 peptide (NP-1) to bind full length FGF-23 was previously shown (Ren et al., 2016b) . In Figure 1A , the specificity of IgY to FGF-23 peptide was demonstrated. IgY from FGF-23 peptide vaccinated hens diluted as much as 1:8,000 showed FGF-23 peptide specific binding when compared to IgY from control vaccinated hens. Figure 1B demonstrated that chicks from FGF-23 peptide vaccinated hens had circulating levels of anti-FGF-23 peptide antibody relative to the control chicks at 14 d of age when plasma was diluted as high as 1:8,000.
Growth Performance
The one to 14 d body weight (gain) and feed intake of the Single Comb White Leghorn × New Hampshire Figure 1 . Anti-FGF-23 antibody levels in vaccinated eggs and progeny. Antibody level to FGF-23 peptide GMNPPPYS (internally coded as NP1) in egg yolk (A, extracted by acidified phosphate-buffered saline) and 14 d chick plasma (B) were determined by diluting the respective samples to 1:1,000, 1:2,000, 1:4,000, and 1:8,000 and reacting them against a FGF-23 peptide-ovalbumen bound conjugate using an indirect enzyme-linked immunosorbent assay. Samples were from eggs (n = 14 to 15) and progeny chicks of FGF-23 peptide and control vaccinated hens. Chicks from FGF-23 peptide and control vaccinated hens were fed either zero or 500 units of phytase/kg diet for 14 d (n = 15). cross used in this study and provided phytase alone or phytase plus FGF-23 antibody were similar to weights and feed intakes of chicks of the same cross fed a phosphate adequate diet in a previous study (Ren et al 2016a) . No difference in BW at d one was observed in chicks with control or anti-FGF-23 maternal antibody (P > 0.05, data not shown). A significant phytase × antibody interaction on BW (P = 0.01), BWG (P = 0.03), and G:F (P = 0.05) was observed on d 14 (Table 2 ). Increased (P < 0.05) BW, BWG, and G:F were observed in chicks with maternally derived anti-FGF-23 antibody but fed no phytase (increased by 9, 15, and 18%, respectively) or chicks fed phytase but with control antibody (increased by 13, 21, and 16% respectively) when compared to chicks with control antibody and not fed phytase. There were no additive effects of combining the maternally derived anti-FGF-23 antibody and dietary phytase on BW, BWG, or G:F. Chicks with the combined treatments had BW, BWG, and G:F similar to those provided either anti-FGF-23 antibody only or dietary phytase only. The increase in BW, BWG, and G:F in chicks with maternally derived anti-FGF-23 antibody and fed phytase were 10, 18, and 16%, respectively, relative to chicks with control antibody and no dietary phytase.
Plasma minerals, Bone Ash, and Excreta Phosphorus
The supplementation of 500 FTU/kg phytase in a 0.2% nPP diet, independent of maternally derived anti-FGF-23antibody, increased plasma levels of phosphate by 11% (P = 0.05) and tibiotarsus ash by 13% (P < 0.01) compared to chicks with no supplemental phytase ( Table 3) . Independent of dietary phytase supplementation, the presence of anti-FGF-23 antibody increased plasma levels of phosphate by 11% (P = 0.05) and tibiotarsus ash by 11% (P < 0.01) when compared to those with control antibody. The presence of significant main effects for both phytase and antibody, without a significant interaction support an additive effect of the 2 independent variables (Snedecor and Cochran, 1967 ; see the statistical analysis section). Excreta phosphorus and plasma calcium were not affected by phytase or the antibody treatment.
Plasma Hormone Levels
The addition of phytase to the diet increased plasma FGF-23 (P = 0.04), but not 1,25 (OH) 2 D 3 , or iPTH, independent of the maternally derived anti-FGF-23 (Table 3) . In this study, the maternally derived anti-FGF-23 antibody had no effect (P >0.05) on plasma hormone levels, and no interaction between phytase and antibody on plasma hormones was found (P > 0.05).
DISCUSSION
The primary objective of this study was to determine if FGF-23 neutralization (using anti-FGF-23 antibody) was additive with dietary phytase on phosphate utilization by the chick. Data provided using chick plasma phosphate and tibiotarsus ash demonstrated anti-FGF-23 antibody and phytase were additive. The additive nature of anti-FGF-23 antibody and dietary phytase on plasma phosphate and tibiotarsus ash was predictable because hydrolysis of phytate by phytase makes phosphorus available for absorption (Waldroup et al., 2000; Li et al., 2015) , while neutralization of FGF-23 makes intestinal phosphate more bioavailable by reducing the signal of the key hormone (FGF-23) that blocks intestinal phosphate absorption and renal phosphate resorption (Bai et al., 2003; Gattineni et al., 2009; Sabbagh et al., 2009) . Phytase increased the chick plasma phosphate level and tibiotarsus ash content independently of anti-FGF-23 antibody because of phytase's ability to make phytic phosphate more available for absorption. During dietary nPP deficiency, intestinal NaPi-IIb is up-regulated to increase phosphate absorption (Hattenhauer et al., 1999; Giral et al., 2009 ) because nPP was the rate limiting nutrient meeting the chicks nutrient needs, hence increased levels of intestinal nPP as a result of phytate digestion would be rapidly transported into circulation. The ability of anti-FGF-23 antibody to increase chick plasma phosphate level and tibiotarsus ash content when chicks were fed a deficient dietary level of nPP is not easily explained by the data provided. In dietary nPP-deficient chicks, circulating FGF-23 levels are reduced by 20% (Perwad et al., 2005; Ren et al., 2016a ) and thus the chicks should be in a physiological state for enhancing phosphate absorption when fed deficient dietary nPP. One possible explanation why anti-FGF-23 antibody increased the plasma phosphate level and tibiotarsus ash content may be that the secretion of FGF-23 rapidly responds to postprandial increases in plasma phosphate, even during deficient nPP intake. Indeed we have observed that plasma FGF-23 level increased over 3 fold in Single Comb White Leghorn laying hen (44 wk old) after a 20 gram meal (consumed within 180 s, unpublished data). FGF-23's half-life is 46 to 58 min (Khosravi et al., 2007) , hence, it is rapidly cleared. Hence, our sampling time may not reflect the considerable fluctuation of plasma FGF-23 that occurs throughout the day.
The mechanism by which anti-FGF-23 antibody may have improved phosphorus status of chicks independently of dietary phytase also may have been through increased levels of 1,25(OH) 2 D 3 (Bai et al., 2003; Sabbagh et al., 2009) . While statistical significance was not achieved in this study, anti-FGF-23 antibody has been shown to increase circulating levels of 1,25(OH) 2 D 3 in both laying hens and chicks (Ren et al., 2016a,b) . Increased 1,25(OH) 2 D 3 can increase intestinal phosphate uptake by the chicken by way of 2 mechanisms. First, 1,25(OH) 2 D 3 or 1α-(OH)D 3 is well recognized to increase the digestibility of phytate phosphate through increased digestion of phytic acid via endogenous intestinal alkaline phosphatase (Davies et al., 1970; Bobeck et al., 2015b) . Second, 1,25(OH) 2 D 3 has been shown to increase the expression of intestinal NaPi-IIb, which should increase the capacity to absorb phosphate (Bai et al., 2003; Sabbagh et al., 2009) . The finding that both anti-FGF-23 antibody and phytase was additive with regards to increasing plasma phosphate and tibiotarsus ash suggests that neutralization of FGF-23 alone was not capable of increasing both digestibility and transport of phosphate as effectively as when it was combined with phytase.
Unlike plasma phosphate and tibiotarsus ash, the effects of maternally derived anti-FGF-23 antibody and dietary phytase on growth and feed efficiency were not additive. Chicks provided maternally derived anti-FGF-23 antibody only or dietary phytase only had improved growth and feed efficiency, but use of both strategies together did not offer additional improvements. The reason anti-FGF-23 antibody and dietary phytase showed no additive effects on growth and feed efficiency of chicks fed deficient dietary nPP may have been due to the achievement of maximal growth and feed efficiency when each strategy was used alone. In our previous study (Ren et al., 2016a) , using the same chicks and under the same experimental conditions, chicks fed a similar diet formulated with the required levels of calcium and nPP had a 14 d BW = 98 g, a body weight comparable to that of chicks in this study either fed phytase only (97 g) or chicks with maternally derived anti-FGF-23 antibody only (94 g). Also, the one to 14 d G:F = 0.43 in Ren et al. (2016a) study was similar to that of chicks either fed phytase only (0.45) or chicks with maternally derived anti-FGF-23 antibody only (0.44) in the current study. Hence, a lower dietary nPP level and/or dietary phytase may have been needed to demonstrate an additive effect on growth and feed efficiency in this study. In addition, dietary needs for nPP to maximize plasma phosphate level and tibiotarsus ash content are higher than dietary levels needed to maximize growth and feed efficiency; hence, growth and feed efficiency are less sensitive indicators of body phosphorus status than plasma phosphate and tibiotarsus ash (Potter, 1988) .
While we are unable to show a reduced level of excreta phosphorus due to dietary phytase in this study, reduced excreta phosphorus due to phytase feeding has been repeatedly observed in many studies (Waldroup et al., 2000; Yan et al., 2003a; Yan et al., 2004) . Others have shown that when nPP was fed at levels similar to those used in this study, excreta phosphorus was inconsistently affected by phytase (Yan et al., 2003b) . In Waldroup et al. (2000) , the phytase-induced excreta phosphorus decrease was not consistent in all of the dietary nPP levels (0.1% to 0.5%). Either other variables interfered with our ability to detect a change in excreta phosphorus or the study lacked power to detect a difference. Previously, in both chicks and laying hens, we showed that anti-FGF-23 antibody significantly reduced percent excreta phosphorus 7 and 23%, respectively (Ren et al., 2016a,b) . In this study, maternally derived anti-FGF-23 antibody reduced percent excreta phosphorus only 4% (P = 0.1), but did not affect total 24 h phosphorus excretion. This is the first study to show that the use of dietary phytase increased the plasma levels of FGF-23 an average of 22%. The increase in plasma FGF-23 levels when phytase is added to a nPP deficient diet is similar to what was reported when chick dietary nPP was increased from 0.2 to 0.45% nPP (Ren et al., 2016a ). While we have previously been able to show that anti-FGF-23 antibodies decrease plasma levels of FGF-23 in laying hens (Ren et al., 2016b) , in this study and another (Ren et al., 2016a) we have not been able to detect a decrease in FGF-23 in the young chicks with circulating levels of anti-FGF-23 antibody. A possible reason we did not detect changes due to the antibody in chicks may be because the plasma levels of FGF-23 in chicks (as high as 128 pg/mL in this study) are lower than levels found in laying hens fed a normal diet (407 pg/mL, dietary nPP = 0.4%). The previously reported significant increase (18%) in plasma 1,25(OH) 2 D 3 in chicks with anti-FGF-23 antibodies and fed 0.2% nPP (Ren at al., 2016a) was similar to the increase in chicks fed 0.2% nPP (with no dietary phytase) in this study (19%); however statistical difference was not detected in this study, possibly due to a lack of statistical power or sampling time.
In conclusion, maternally derived anti-FGF-23 antibody and dietary phytase additively increased plasma phosphate level and tibiotarsus ash content of chicks fed 0.2% nPP diet. This is probably due to the dual benefit of both increased digestibility of dietary phytate phosphate and increased absorption and retention of phosphate due to the neutralization of FGF-23.
